Connect with us

Politics

Psychedelics Decrim Activists Mark First Anniversary Of Denver’s Historic Psilocybin Mushroom Vote

Published

on

One year ago on Thursday, activists behind a first-of-its-kind drug policy reform ballot initiative in Denver were anxiously awaiting the results of a local vote that stood to set the city apart from any other in the country. Things didn’t look promising near the end of the night when they were behind—but as the votes continued to trickle in through the next day, it became official: The city had become the first place in the U.S. to decriminalize so-called magic mushrooms.

The Decriminalize Denver campaign defied odds and expectations. Psilocybin was just entering into the mainstream lexicon, there weren’t any large and monied psychedelics advocacy groups chipping in and voter confusion about what it meant to decriminalize—rather than allow retail sales like is the case for marijuana—threatened to derail the bold initiative.

But through a combination of education, outreach and innovation—as well as the open-mindedness of the local electorate—the campaign prevailed. More remarkable than the policy change in Denver, however, is the national grassroots movement it has inspired in the year since the historic vote.

Activists in more than 100 cities across the U.S. have now expressed interest in reforming their own psychedelics policies. Two more cities—Oakland and Santa Cruz—went a step further than Denver and decriminalized a wide range of entheogenic substances such as ayahuasca and ibogaine.

Oregon advocates are close to qualifying a statewide ballot initiative to legalize psilocybin for therapeutic use for this November. Washington D.C. activists were approved to circulate a petition to decriminalize various psychedelics in the nation’s capital on Wednesday. A California campaign had hopes of putting psilocybin legalization on the ballot before the coronavirus pandemic. And psychedelics reform bills have been introduced in three state legislatures.

On the congressional level, Rep. Earl Blumenauer (D-OR) has endorsed the Oregon psilocybin initiative and Rep. Alexandria Ocasio-Cortez (D-NY) introduced an amendment to encourage research into the medical potential of psychedelics. That was defeated on the House floor, but she plans to file more legislation on the issue.

In other words, a lot has happened in a year. And it is difficult to believe that the movement for drug policy reform beyond cannabis would have organized and spread this quickly were it not for what happened in Denver. Kevin Matthews, who led that campaign and has since launched a national advocacy group called SPORE, told Marijuana Moment that he “always looked at Decriminalize Denver and the Denver Psilocybin Initiative as an experiment for how to change laws around psychedelics.”

“Denver was the first step and we still have a lot of work to do,” he said. “What I didn’t necessarily expect was how quickly the landscape would evolve and how it would be this massive, national—perhaps even global—conversation now.”

The success of the campaign “just shocked people,” he said. “I think it really showed that you have a committed, passionate group of people who are brave enough to step into this space and really put their blood, sweat and tears, energy and, in some ways, livelihoods on the line to progress something. We were another example of that, right?”

More and more examples have formed in the past year, with activists working overtime to convince local legislators and residents that criminalizing people for using entheogenic substances is the wrong path. Instead, the plants and fungi should be viewed through the lens of civil liberties and public health, they say, citing research indicating that these currently illicit drugs hold significant therapeutic potential for the treatment of conditions such as severe depression and post-traumatic stress disorder.

One of the main reform groups that has emerged in the space since Denver is called Decriminalize Nature (DN)—a national hub for campaigns to lean on as they pursue local and state policy changes. Chapters across the country are raising awareness, exploring the ballot process for reform and communicating with lawmakers about the need to take a new approach to psychedelics.

Larry Norris, who cofounded Decriminalize Nature, told Marijuana Moment that “Denver’s success cast light on a space beyond the veil of possibilities.”

“They were the first to bring the important conversation about decriminalization to the table, and in the end, the power of the people prevailed. Even the victory was a great underdog story,” he said. “To come back from behind, after almost every news organization reported the initiative had failed the previous evening, provided great media attention for the larger policy conversation. Their success also gave a boost of confidence to Decriminalize Nature, who was able to share Denver’s victory with the Oakland City Council-Members shortly before the public hearings began in Oakland.”

Oakland activists aren’t stopping at decriminalization, either, with plans now in the works to propose a local regulatory model for a limited retail system for entheogenic substances.

David Bronner, CEO of the activist soap company Dr. Bronner’s, which is funding several psychedelics reform campaigns across the country, told Marijuana Moment that the vote in Denver last year “showed that it’s now politically possible to win our right to life-saving psychedelic medicine at this moment of the cultural psychedelic renaissance, and directly paved the way for Decrim Oakland to make magic happen there, and the birth of now national and international Decrim Nature movement.”

“It set a good precedent of talking about psychedelic medicine in the healing therapeutic frame, with a strong educational component about proper preparation, set and setting, and integration after,” he said.

There have been some reform supporters who have questioned whether decriminalization campaigns could detract from the rigorous, federally authorized studies into the therapeutic benefits of psychedelics that are in the works. Author Michael Pollan, for example argued in a New York Times op-ed shortly after the Denver vote that “ballot initiatives may not be the smartest way” to change laws around the substances. He later seemed to walk back that stance somewhat after pushback from advocates, however.

Natalie Ginsberg, director of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and gaining approval for clinical trials into several substances, told Marijuana Moment that for decades, “psychedelic research has been paving the way for psychedelic medicine, but medical access is not enough—decriminalization must go hand-in-hand with medicalization for a healthful society.”

Bronner also contended in a blog post last year that bringing the underground psychedelics world aboveground through a state-licensed treatment model in advance of federal approval “provides an example outside of the traditional pharma model for responsible regulated adult access to psilocybin therapy.”

“It’s also important to understand that the state ballot measure process is the only political mechanism that exists for providing this kind of broad responsible adult access,” whereas psychedelic-based pharmaceuticals could be less accessible, he said.

Advancements are being made in the traditional research realm as well, with Johns Hopkins University announcing last year that it is launching the nation’s first center devoted exclusively to studying psychedelic drugs.

What’s to come in the year ahead? The current pandemic might have created challenges for political campaigns of late, but assuming society returns to some level of normalcy, advocates anticipate an even bigger wave of reform—another year of progress that challenges the status quo of prohibition and demonstrates the need for a psychedelics renaissance.

Bronner predicted that “we’re going to see most large urban cities in America decriminalize mushrooms and plant medicines in the next few years,” adding that he believes Food and Drug Administration approval of psychedelic therapies will happen and Oregon will legalize psilocybin for therapeutic use. That will “pave the way to mainstream acceptance and widespread psychedelic healing of the people of the world by the end of the decade,” he said.

Norris conceded that it’s “uncertain how quickly things will reopen post COVID-19 shutdown and when city councils will be able to address these policies again” and the pandemic “obviously had a great impact on those with ballot initiatives who need to gather signatures.”

“However, many DN teams are working hard behind the scenes to prepare for the eventual reopening. Taking our cue from nature, DN is currently in a phase of nourishing our roots, rather than fruiting and blossoming,” he said, adding that the organization has been holding virtual meetings with activists across the country and globe. “Assuming things resume in a timely manner, we project at least five to seven more cities will Decriminalize Nature by the end of 2020.”

Among some drug policy reform advocates, there’s a lingering question about focusing decriminalization efforts on a singular class of substances, rather than ending the drug war altogether by removing criminal penalties for all currently illicit drugs.

Matthews said he agrees that reform shouldn’t end with psychedelics. “I absolutely support the broader decriminalization of all drugs,” he said. “Our campaign in many ways opened the door for us to have a direct conversation with the city—a very direct conversation with the city—about how it enforces their drug policy. We need alternatives to the current drug policy paradigm.”

“All substances absolutely need to be decriminalized because they’re mostly non-violent and victimless crimes, and we need to focus more on treatment where it’s necessary,” he said. “The psychedelics drug policy movement can very much inform and help galvanize the broader drug policy decriminalization movement. Denver is a good example of that based on the messaging we’ve got from the city.”

Ginsberg at MAPS said that “Denver’s move to deprioritize psilocybin arrests ignited communities across the country to mobilize to deprioritize all entheogenic plants, cacti and fungi, or ‘decriminalize nature’,” adding that she’s “hopeful that these psychedelic movements will join forces with broader coalitions to end the war on drugs and fully decriminalize all drugs.”

“In times of pandemic it’s clearer than ever that mass incarceration, and mass criminalization, are fundamentally incompatible with public health,” she said.

Broader decriminalization campaigns might not yet be taking off at the speed of the psychedelics reform movement, but there are proposed statewide initiatives in Oregon and Washington state to fully end the criminalization of drug possession while expanding treatment services.

In the meantime, Matthews had this to say to activists in the early stages of exploring psychedelics reform:

“Be committed, and that takes discipline. Folks definitely need to explore—both internally, to have experience with these substances to really understand it, and then find the others. That takes bravery because you’re stepping out as a psychedelics user in a sense. Then start broadcasting. Start sharing information. Social media, email your network—broadcast, broadcast, broadcast, and do it with integrity. Be very open about both the therapeutic and medical potential and the risks. That’s very important.”

“If you’re committed, a part of that involves faith and trust in the process,” he said. “This movement certainly has a mind of its own. If anyone out there wants to dedicate their livelihood to this, then they will be supported by the microverse.”

Decriminalization might be on the books now as Denver’s official policy thanks to the vote one year ago, but Matthews and other advocates are still at work educating city officials and ensuring that the change is implemented effectively, with an eye toward justice. A panel comprised of city officials, law enforcement and advocates, which was mandated by the ballot measure, held its third meeting on Wednesday—two months after the group established tracking and reporting criteria for police activity related to psilocybin post-decriminalization.

Now, thanks to Denver voters’ decision last May, the city is home to the nation’s first government psychedelics decriminalization body, but it is not likely to be the last.

Campaign To Decriminalize Psychedelics In DC Cleared For Signature Gathering

Photo courtesy of Wikimedia/Mushroom Observer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Politics

California Senator Seeks Federal Clarification On Medical Marijuana Use In Hospitals

Published

on

A California senator is asking the head of the U.S. Department of Health and Human Services (HHS) to provide clarification on whether hospitals and other healthcare facilities in legal marijuana states can allow terminally ill patients to use medical cannabis without jeopardizing federal funding.

State Sen. Ben Hueso (D) on Thursday sent a letter to HHS Secretary Xavier Becerra and Centers for Medicare and Medicaid Services (CMS) Administrator Chiquita Brooks-LaSure inquiring about the policy. Confusion about possible implications for permitting marijuana consumption in health facilities led pro-legalization Gov. Gavin Newsom (D) to veto a bill meant to address the issue in 2019.

Hueso refiled a nearly identical version of the legislation for this session, and it’s already passed the full Senate and one Assembly committee. It’s now awaiting action on the Assembly floor before potentially being sent to Newsom’s desk.

“Ryan’s Law would require that hospitals and certain types of healthcare facilities in the State of California allow a terminally-ill patient to use medical cannabis for treatment and/or pain relief,” the senator wrote in the letter to the federal officials, with whom he is asking to meet to discuss the issue. “Currently, whether or not medical cannabis is permitted is left up to hospital policy, and this creates issues for patients and their families who seek alternative, more natural medication options in their final days.”

Hospitals that receive CMS accreditation are generally expected to comply with local, state and federal laws in order to qualify for certain reimbursements. And so because marijuana remains federally illegal, “many healthcare facilities have adopted policies prohibiting cannabis on their grounds out of a perceived risk of losing federal funding if they were to allow it.”

But Hueso said that his office received a letter from CMS several months ago stating that there are no specific federal regulations in place that specifically address this issue and that it isn’t aware of any cases where funding has been pulled because a hospital allows patients to use medical cannabis.


Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Additionally, because the Justice Department has been barred under annually renewed spending legislation from using its funds to interfere in the implementation of state-level medical marijuana programs, the senator said, “we believe the risk of federal intervention is little to none.”

“This confirmation from CMS been quite a breakthrough and we are optimistic it will alleviate the Governor’s concerns,” the letter continues. “However, I want to underscore that, prior to receiving this response, even the Governor of California was under the impression that CMS rules prohibited hospitals and healthcare facilities from allowing medical cannabis use.”

“Undoubtedly other states are struggling with this issue, too,” it says. “As more states decriminalize cannabis and even create recreational markets, we must not forget to also update the books for the most important consumers of all—patients.”

“While ideally the federal government will remove cannabis from its Schedule I designation, I appreciate that this is a lengthy and complex process. In the interim, it would be extremely helpful if you could provide clarification that assures Medicare/Medicaid providers that they will not lose reimbursements for allowing medical cannabis use on their premises. This clarification would go a long way to help hospital staff, security, above all, patients.”

Becerra, while previously serving as California attorney general and as a member of Congress, demonstrated a track record of supporting marijuana law reform.

Meanwhile, there are efforts in both chambers of Congress to end federal marijuana prohibition.

Senate Majority Leader Chuck Schumer (D-NY), Senate Finance Committee Chairman Ron Wyden (D-OR) and Sen. Cory Booker (D-NJ) are currently soliciting feedback on draft legalization legislation they introduced this month.

Meanwhile, a separate House bill to federally legalize marijuana and promote social equity in the industry was reintroduced in May.

The legislation, sponsored by Judiciary Committee Chairman Jerrold Nadler (D-NY), was filed with a number of changes compared to the version that was approved by the chamber last year.

Read the letter from the California senator to Becerra below: 

Marijuana hospital letter t… by Marijuana Moment

Rhode Island House Speaker Says ‘No Consensus’ On Marijuana Legalization, But It’s ‘Workable’

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Rhode Island House Speaker Says ‘No Consensus’ On Marijuana Legalization, But It’s ‘Workable’

Published

on

A top Rhode Island lawmaker says that while there’s not yet a consensus among legislators and the governor on a bill to legalize marijuana, it’s still a “workable” issue and would be prioritized if a special session is convened this fall.

House Speaker Joe Shekarchi (D) told The Public’s Radio that it’s “possible” that a special session will be held later in the year after lawmakers failed to reach a deal on competing reform proposals.

“It really depends if we can come to some kind of resolution of consensus on a couple of major bills,” he said, referring to cannabis and a handful of other issues. “If we can, we certainly would come back.” But if not, members will continue to discuss the proposals and prepare to take them up at the start of the next session in January.

“Unfairly, sometimes I have or the House gets blamed for stopping the legalization of recreational use of marijuana, when in reality there is no consensus,” he said. “If we can come to some closeness, in the several different proposals, then we’ll move some kind of legislation. But if not, it just needs more work—and it’s very workable, so it’s very much something that can happen, we just have to put the effort in and make it happen.”

Listen to the speaker discuss the marijuana legalization plan, about 1:00 into the audio  below: 

Shekarchi similarly told Marijuana Moment in an email earlier this week that he’s “not opposed to the legalization of recreational marijuana,” but “there have been very divergent proposals offered by Representative Scott Slater, the Senate, the governor and various advocacy groups.”

“As I have done with other issues, my role will be to bring the parties together and see if we can reach a consensus,” he said. “I will be working on the issue this summer and fall, and if an agreement can be reached, it is possible that one piece of legislation will be brought before the legislature for future consideration. But there is a lot of work to be done to reach consensus.”

Shekarchi and other top lawmakers have previously said they will work this summer to try to reach a compromise on the differing provisions of the competing legalization plans.

Senate President Dominick Ruggerio (D) said earlier this month that he’s not disappointed the House hasn’t advanced legalization legislation yet and that “what we really wanted to do was send it over and have them take a look at it” when his chamber passed a cannabis reform measure last month.

Shekarchi previously said that he feels reform is “inevitable.”


Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

A key disagreement between the House, Senate and governor’s office concerns who should have regulatory authority over marijuana. Ruggerio was pressed on the issue during the recent interview and said members of his chamber agree that “a separate commission is the way to go with respect to this.”

The House and Gov. Dan McKee (D), on the other hand, want the program to be managed by the state Department of Business Regulation (DBR). Ruggerio noted that “it was difficult to negotiate on a bill when the House bill really didn’t come until late in the session.”

Asked whether he felt the legislature and governor could come to an agreement despite the differences, Senate Majority Leader Mike McCaffrey (D) said this month that “that’s what our goal is.”

“Obviously there’s some issues that different people have relative to different categories of licenses and things like that and how we’re rolling them out,” he said. “Are we going to limit them? what type of equity are you going to give to the different people in different communities so that they can get into the business? And social equity and things of that nature.”

McCaffrey was also asked about provisions related to allowing local municipalities to opt out of allowing marijuana businesses to operate in their area. He said “once the legislation is passed and whatever form is passed in, the communities have an opportunity to opt out.”

“They have an opportunity to opt out if the community doesn’t want to participate in it,” he said. “That’s their decision—however, they don’t get the funds that would come from the sales in that community.”

The majority leader also noted that neighboring states like Connecticut and Massachusetts have enacted legalization, and that adds impetus for the legislature to pursue reform in the state. .

Shekarchi, meanwhile, said this month that he doesn’t intend to let regional pressure dictate the timeline for when Rhode Island enacts a policy change. But it is the case that legalization has now gone in effect in in surrounding states like Connecticut and Massachusetts.

“I’m not in any hurry to legalize marijuana for the sake of legalizing it. I want to do it right,” he said. “It doesn’t matter to me if we’re the last state in the union to legalize it or we never legalize it, but I need to do it right.”

Social equity, licensing fees, labor agreements and home grow provisions are among the outstanding matters that need to be addressed, Shekarchi said.

These latest comment come weeks after the state Senate approved a legalization bill from McCaffrey and Health & Human Services Chairman Joshua Miller (D), which was introduced in March. The governor also came out with his own legalization proposal shortly thereafter.

A third Rhode Island legalization measure was later filed on the House side by Rep. Scott Slater (D) and several cosponsors. The House Finance Committee held a hearing on the measure last month.

The governor, for his part, told reporters that while he backs legalization it is “not like one of my highest priorities,” adding that “we’re not in a race with Connecticut or Massachusetts on this issue.”

“I think we need to get it right,” he said, pointing to ongoing discussions with the House and Senate.

The House Finance Committee discussed the governor’s proposal to end prohibition at an earlier hearing in April.

Both the governor and the leaders’ legalization plans are notably different than the proposal that former Gov. Gina Raimondo (D) had included in her budget last year. Prior to leaving office to join the Biden administration as commerce secretary, she called for legalization through a state-run model.

McKee gave initial insights into his perspective on the reform in January, saying that “it’s time that [legalization] happens” and that he’s “more leaning towards an entrepreneurial strategy there to let that roll that way.”

Shekarchi, meanwhile, has said he’s “absolutely” open to the idea of cannabis legalization and also leans toward privatization.

Late last year, the Senate Finance Committee began preliminary consideration of legalization in preparation for the 2021 session, with lawmakers generally accepting the reform as an inevitability. “I certainly do think we’ll act on the issue, whether it’s more private or more state,” Sen. Ryan Pearson (D), who now serves as the panel’s chairman, said at the time.

Meanwhile, the governor this month signed a historic bill to allow safe consumption sites where people could use illicit drugs under medical supervision and receive resources to enter treatment. Harm reduction advocates say this would prevent overdose deaths and help de-stigmatize substance misuse. Rhode Island is the first state to allow the facilities.

The Senate Judiciary Committee also held a hearing in March on legislation that would end criminal penalties for possessing small amounts of drugs and replace them with a $100 fine.

Ohio Lawmakers Officially File Marijuana Legalization Bill In Historic First For The State

Photo courtesy of WeedPornDaily.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Ohio Lawmakers Officially File Marijuana Legalization Bill In Historic First For The State

Published

on

Ohio lawmakers on Friday formally introduced a bill to legalize marijuana possession, production and sales—the first effort of its kind in the state legislature. This comes as activists are pursuing a separate ballot initiative that would effectively force the legislature to consider similar cannabis reforms.

Reps. Casey Weinstein (D) and Terrence Upchurch (D) filed the legislation, weeks after circulating a co-sponsorship memo to colleagues to build support for the measure.

The 180-page bill would legalize possession of up to five ounces of cannabis for adults 21 and older and allow them to cultivate up to 12 plants for personal use. It also includes provisions to expunge prior convictions for possession and cultivation activities that are being made legal under the measure.

A 10 percent excise tax would be imposed on marijuana sales, with revenue first going toward the cost of implementation and then being divided among municipalities with at least one cannabis shop (15 percent), counties with at least one shop (15 percent), K-12 education (35 percent) and infrastructure (35 percent).

“It’s time to lead Ohio forward,” Weinstein said in a press release. “This is a big step for criminal justice reform, for our veterans, for economic opportunity, and for our individual liberties.”

The state Department of Commerce would be responsible for overseeing the program and issuing cannabis business licenses.


Marijuana Moment is already tracking more than 1,200 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.

Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.

Individual municipalities could restrict the type and number of marijuana that operate in their area. The bill specifically states that the state’s existing medical marijuana program would not be impacted by the establishment of an adult-use market.

“This bill is much needed in Ohio, and it’s time for Ohio to become a national leader in marijuana decriminalization and legalization,” Upchurch said. “This bill is more than just about legalization, it’s about economic and workforce development, it’s about decriminalization, and it’s about healthcare! The time is now, and I look forward to getting this done in a bipartisan fashion.”

Gov. Mike DeWine (R) is likely to oppose the effort given his record, but activists have effectively demonstrated through local initiatives that voters in the state broadly support enacting a cannabis policy change.

A newly formed organization called the the Coalition to Regulate Marijuana Like Alcohol (CTRMLA) is also actively collecting signatures for a statewide ballot measure that would separately force lawmakers to consider taking up legalization legislation once a certain signature gathering threshold is met.

“I’m glad to see it! It’s added momentum toward legalization,” Weinstein told Marijuana Moment earlier this week of the ballot effort. “And hopefully a looming ballot initiative will add some incentive for my Republican colleagues to work with me on my bill.”

Meanwhile, 22 jurisdictions have adopted local statues so far that reduce the penalty for low-level cannabis possession from a misdemeanor punishable by jail time and a fine to the “lowest penalty allowed by state law.” And activists are pursuing similar policy changes in dozens of cities this year.

Don Keeney, executive director of NORML Appalachia, told Marijuana Moment that local officials have so far certified decriminalization initiatives in five cities they were targeting this year: Laurelville, McArthur, Murray City, New Lexington and New Straitsville.

Ohio activists had hoped to place a cannabis legalization initiative on the statewide ballot last year, but that effort stalled as the COVID-19 outbreak and resulting public health restrictions made signature gathering all but impossible.

Local advocates sought relief through the court system to make it so they could collect signatures electronically for 2020 ballot initiatives, but the lawsuit was repeatedly rejected—most recently by the U.S. Circuit Court of Appeals for the Sixth Circuit, which ruled on Wednesday that the challenge was no longer relevant because last year’s election has passed and the case was therefore moot.

Read the text of the Ohio marijuana legalization bill below: 

Ohio marijuana legalization… by Marijuana Moment

GOP Senator Sponsoring Marijuana Banking Bill Proposes Controversial Welfare Restrictions For Cannabis Purchases

Photo courtesy of Mike Latimer.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Marijuana News In Your Inbox

Support Marijuana Moment

Marijuana News In Your Inbox

Marijuana Moment